A type-II kinase inhibitor capable of inhibiting the T315I "gatekeeper" mutant of Bcr-Abl.
Choi HG, Ren P, Adrian F, Sun F, Lee HS, Wang X, Ding Q, Zhang G, Xie Y, Zhang J, Liu Y, Tuntland T, Warmuth M, Manley PW, Mestan J, Gray NS, Sim T.
Choi HG, et al. Among authors: gray ns.
J Med Chem. 2010 Aug 12;53(15):5439-48. doi: 10.1021/jm901808w.
J Med Chem. 2010.
PMID: 20604564
Free PMC article.